Göral, VedatGöral, Kerem MertÖrmeci, Necati2021-12-102021-12-102021Göral, V., Kerem, M., Göral, & Örmeci, N. (2021). Follow-up strategies in focal liver lesions and treatment methods. Journal of Gastroenterology & Hepatology Reports, 2(4), pp. 1–6. https://doi.org/10.47363/JGHR/2021(2)123https://doi.org/10.47363/JGHR/2021(2)123https://hdl.handle.net/20.500.13055/78Today, advances in cross-sectional imaging have led to the detection and early recognition of incidental/focal liver lesions (FCL). In approximately 17,000 cases of chest CT, incidental liver lesions were found in 6% [1]. In general, FCL consists of hepatocytes, biliary epithelium, mesenchymal tissue, connective tissue, or metastasized cells from distant sites. Most incidental lesions are benign, some may require careful management and treatment. In evaluating the lesion, the patient’s clinical history, underlying disease and age factor should be considered. FCL can be detected at a rate of 10-30% in normal healthy and chronic liver disease patients, and even in oncology patients with malignancy, FCLs can be highly benign (50-80%).eninfo:eu-repo/semantics/openAccessFocal Liver LesionsFollow-UpArticle10.47363/JGHR/2021(2)1232416